# Risk factors for identifying pulmonary aspergillosis in pediatric patients

**Authors:** Shangmin Yang, Yanmeng Sun, Mengyuan Wang, Huan Xu, Shifu Wang

PMC · DOI: 10.3389/fcimb.2025.1616773 · Frontiers in Cellular and Infection Microbiology · 2025-06-27

## TL;DR

This study identifies key risk factors and creates a predictive model to help diagnose pulmonary aspergillosis in children.

## Contribution

A high-performance predictive model for pediatric pulmonary aspergillosis using six clinical risk factors is developed and validated.

## Key findings

- Six independent risk factors for pediatric pulmonary aspergillosis were identified, including surgery history and viral coinfection.
- The predictive model showed excellent discrimination (AUC 0.93) and calibration for diagnosing PA.
- Metagenomic sequencing revealed higher polymicrobial infection rates in PA cases compared to non-PA cases.

## Abstract

This study aimed to identify the independent risk factors and develop a predictive model for pulmonary aspergillosis (PA) in pediatric populations.

This retrospective study compromised 97 pediatric patients with pulmonary infections (38 PA cases and 59 non-PA cases) at Children’s Hospital Affiliated to Shandong University between January 2020 and October 2024. Multivariate binary logistic regression was used to identify PA-associated risk factors. Receiver operating characteristic (ROC) curves, calibration plots, and Brier scoring were used to evaluate the diagnostic model.

8 clinical variables significantly differed between the PA and non-PA groups. Multivariate binary logistic regression analysis identified six significant independent risk factors: a history of surgery (OR: 9.52; 95% CI: 1.96–46.23; P = 0.005), hematologic diseases (OR: 11.68; 95% CI: 0.89–153.62; P = 0.062), absence of fever (OR: 8.244; 95% CI: 1.84–36.932; P = 0.006), viral coinfection (OR: 15.99; 95% CI: 3.55–72.00; P < 0.001), elevated (1, 3) -β -D-glucan levels (BDG, > 61.28 pg/mL; OR: 7.38; 95% CI: 1.26–43.31; P = 0.027), and shorter symptom-to-admission interval (< 4.5 days; OR: 38.68; 95% CI: 5.38–277.94; P < 0.001) were risk factors for PA. The predictive model demonstrated excellent discrimination (AUC 0.93, 95% CI 0.88-0.98) and calibration (Hosmer-Lemeshow p=0.606, R²=0.96, Brier score 0.097). metagenomic next - generation sequencing (mNGS) revealed significantly higher rates of polymicrobial infections in PA cases (86.84% vs 18.64%, p<0.001).

This study established and validated a high-performance predictive model incorporating six clinically accessible parameters for the diagnosis of pediatric PA.

## Linked entities

- **Chemicals:** (1, 3)-β-D-glucan (PubChem CID 71312131)

## Full-text entities

- **Diseases:** PA (MESH:D055732), hematologic diseases (MESH:D006402), infections (MESH:D007239), pulmonary infections (MESH:D012141), fever (MESH:D005334)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12245894/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12245894/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12245894/full.md

---
Source: https://tomesphere.com/paper/PMC12245894